Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity
有髓鞘啮齿动物脑球体用于神经毒性的高通量评估
基本信息
- 批准号:10079810
- 负责人:
- 金额:$ 22.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-09 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdvanced DevelopmentAnimal ModelAnimal TestingAnimalsAstrocytesAwardBehavioralBiologicalBiological AssayBiological ModelsBiological ProcessBiomimeticsBlindnessBrainCell Culture TechniquesCell modelCellsCharacteristicsChemical ExposureChemicalsClinicalCognitive deficitsConfocal MicroscopyDataDemyelinationsDevelopmentDoseElectrophysiology (science)EmbryoEngineeringEnvironmentEvaluationFunctional disorderFunding OpportunitiesGoalsGrowthHearingHumanHuman BiologyImageImage AnalysisImpaired cognitionImpairmentIn VitroIndustrial WasteIndustrializationLearningLegal patentLibrariesMeasuresMemory LossMethodsMicroelectrodesModelingMotorNervous system structureNeuraxisNeurogliaNeuronsNeurosciencesOligodendrogliaOrganoidsPatternPeripheral Nervous SystemPhasePhysiologicalPilot ProjectsPositioning AttributeReflex actionResearchRodentRunningSensitivity and SpecificitySensoryStructureSymptomsSystemTechnologyTestingThree-Dimensional ImageTimeTissue MicroarrayTissuesToxic Environmental SubstancesToxic effectToxicity TestsToxicologyToxinValidationanimal databasebehavior testclinical predictorsconfocal imagingcytotoxicitydata modelingdosagedrug efficacyexperimental studyhigh throughput screeninghuman tissueimaging systemimprovedin vitro Assayin vivoinduced pluripotent stem cellinnovationmedication safetymicrophysiology systemmicroscopic imagingmulti-electrode arraysneuron lossneuropathologyneurotoxicneurotoxicityorgan on a chipphase 1 studyrelating to nervous systemresponsescale upscreeningstem cell technologythree dimensional cell culturetoxicanttoxicant screening
项目摘要
Central nervous system (CNS) toxicity results in a wide variety of functional and behavioral changes in animal
models such as cognitive impairments, learning/memory loss, hearing/vision loss, alterations in sensory/motor
reflex, and several other dysfunctions. While behavioral tests and animal models are sensitive enough to predict
human neurotoxicity, the expense and labor-intensiveness of animal testing make it challenging to screen large
numbers of chemical compounds. While running behavioral tests is not possible in in vitro setting, some
parameters that can be evaluated include cytotoxicity of neuronal and glial cell bodies, demyelination, or altered
neuronal firing patterns, which many toxins are known to impact and ultimately results in behavioral/cognitive
deficits. Recent advances in induced pluripotent stem cell technology have resulted in the development of human
cells-based microphysiological systems that have shown tremendous promise as advanced cellular models that
can provide high-throughput and high-content data useful for toxin screening. While human organoids are
expected to predict human neurotoxicity better than animal models, the data generated using human organoids
may not be reliable enough unless studies show that in vitro neurotoxicity successfully predicts in vivo cortical
dysfunctions shown in the historical animal studies. To overcome these challenges and strengthen findings
obtained by human brain organotypic culture systems, we have developed an innovative functionally mature 3D
rodent brain spheroid model of consistent size and unvarying composition by culturing embryonic dissociated
cortical tissue.
The objective of this phase I study is to demonstrate that certain chemical toxins known for causing
neurotoxicity in rodents will induce toxicity in micro-engineered neural tissue that can be quantified using 3D
image analysis, neuronal firing patterns and histomorphometry. This goal will be achieved by quantifying discrete
biological and electrical quantifiable metrics by which untreated brain spheroids can be demonstrated to differ
significantly compared to treated controls.
This goal will be accomplished in two phases: The research plan will consist of first developing and
characterizing 3D rodent brain spheroids using high throughput confocal screening and microelectrode arrays
for baseline biological and functional evaluation. (Aim 1). Then, we will compare biological and
electrophysiological characteristics of cultured untreated spheroids with spheroids treated with environmental
toxins to validate the assay in the presence of an insult (Aim 2).
Successful completion of these aims will strongly position this technology for a Phase II award, in which
we will seek to scale up fabrication and testing and fully validate the specificity and sensitivity of the clinically-
analogous metrics with a larger library of compounds, as compared with animal data. We will further perform
“omics” studies and will eventually use this assay for determining a large spectrum of toxicological parameters
resulting in understanding mechanisms of action as well as improved understanding of biological processes.
中枢神经系统(CNS)毒性导致动物各种各样的功能和行为改变
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jabe L Curley其他文献
Jabe L Curley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jabe L Curley', 18)}}的其他基金
Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing
用于预测性临床前药物测试的外周神经芯片
- 批准号:
10492954 - 财政年份:2016
- 资助金额:
$ 22.79万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别: